Five Year Results fom Amulet™ LAA Randomized Controlled Trial
Largest LAAO Randomized Controlled Trial Through 5 Years
5-year outcomes of Amulet and Watchman LAA occluders in a randomized trial has been assessed and were reported at the AHA 2024 congress.
The Amulet IDE trial evaluated the safety and effectiveness of the Amulet occluder with dual-seal technology compared to the single lobe watchman in patients with nonvalvular atrial fibrillation.
TRENDING TOPICS
2-year outcomes from the TRILUMINATE Pivotal trial
Amplatzer™ Amulet™ LAA Occluder
Epic Mitral – 10-Year Clinical Outcomes
